Target intelligence / Profile preview

Off-target mRNAs with partial complementarity to the DLST siRNA guide strand

Molecular classification
Messenger RNA (mRNA), Nucleic acid
01

Overview

Off-target mRNAs with partial complementarity to the DLST siRNA guide strand represent a diverse group of unintended genetic transcripts that are downregulated during RNA interference (RNAi) experiments targeting Dihydrolipoamide S-Succinyltransferase (DLST). This phenomenon occurs when the siRNA guide strand recognizes and binds to mRNAs that share sequence similarity, particularly in the 3' untranslated region (UTR), a process often driven by the 6-8 nucleotide 'seed' sequence [1]. DLST itself is a vital enzyme in the mitochondrial tricarboxylic acid (TCA) cycle, and its silencing is frequently investigated in oncology and metabolic research [2]. However, the silencing of these off-target mRNAs can induce cellular phenotypes, such as reduced viability or altered metabolism, that are independent of the intended DLST knockdown [3]. These interactions represent a major challenge in the development of siRNA-based therapeutics, as they can lead to unforeseen toxicities and complicate the interpretation of biological data [4]. Consequently, these mRNAs are not therapeutic targets but are critical factors to be minimized through chemical modification or optimized sequence design in drug development.

Other names
DLST siRNA off-targetsSeed-sequence-dependent off-target transcriptsUnintended siRNA-mediated gene silencingDLST siRNA-induced off-target effects
02

Mechanism of action

The DLST siRNA guide strand incorporates into the RNA-induced silencing complex (RISC) and binds to off-target mRNAs via partial complementarity, primarily through the seed region (nucleotides 2-8), leading to mRNA cleavage or translational inhibition.

03

Biological functions

Protein synthesis templateRegulation of gene expression
04

Disease associations

Off-target toxicityUnintended gene silencingCellular stress response
05

Safety considerations

Off-target toxicityUnintended phenotypic changesConfounding of experimental resultsCytotoxicity
06

Interacting drugs

DLST siRNA
07

Biomarkers

Differential gene expression profiling (RNA-seq)Quantitative PCR (qPCR) of off-target transcriptsReporter gene assays for 3' UTR binding

Beyond the preview

Go deeper on Off-target mRNAs with partial complementarity to the DLST siRNA guide strand.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Off-target mRNAs with partial complementarity to the DLST siRNA guide strand.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call